Oxford Hospitals to Enhance Research with £1 Million Funding

Oxford University Hospitals NHS Foundation Trust (OUH) has secured a funding boost of £1,018,380 from the National Institute for Health and Care Research (NIHR) to enhance its clinical research capabilities. This significant investment will allow OUH to procure advanced equipment, facilitating studies in areas such as respiratory care, vaccine development, imaging, and experimental medicine.

Dr Chris Bray, head of research and development operations at OUH and a joint lead applicant for the funding, expressed enthusiasm about the award. He stated, “We are absolutely delighted that the NIHR has agreed to fund this equipment. It will allow Oxford University Hospitals – together with our partners at the University of Oxford – to expand its research capacity and press ahead with a wide range of new studies that will benefit NHS patients.”

Expanding Research and Patient Care

The funding has been awarded following a competitive national process and will bolster OUH’s existing roles, including its responsibilities as a host for the NIHR Oxford Biomedical Research Centre (BRC) and the NIHR Oxford Clinical Research Facility (CRF). The new equipment is expected to yield operational benefits for patient care, enabling the hospital to respond to the increasing demand for commercially sponsored clinical trials.

Professor Andrew Brent, chief medical officer at OUH, highlighted the importance of research and innovation in the hospital’s strategy. “Our research teams also sometimes share equipment with our clinical teams, so a significant additional benefit of capital funding like this is that it relieves demand on equipment used for clinical work, while at the same time allowing us to increase our research portfolio,” he noted.

The investment will support various upgrades, including facilities for early-phase clinical trials, imaging equipment specifically designed for respiratory studies, and advanced tools for lung function and endoscopic research. Additionally, the funding will enhance capabilities in vaccine research through improved PCR and sequencing technologies.

Supporting NHS Goals and Innovation

Further investments will provide new DXA scanners for metabolic and liver studies, high-resolution imaging for retinal research, increased sample storage and analysis capacity, and home telemetry kits to support remote monitoring in epilepsy trials. Professor Chris Buckley, director of the NIHR Oxford CRF and lead applicant, commented on the significance of this funding, stating, “This funding for new infrastructure will give an important boost to the work being carried out by the NIHR Oxford BRC and NIHR Oxford CRF, who, working with patients and the public, are translating innovative scientific ideas into tangible new treatments and diagnostic tools for our patients.”

This new equipment aligns with broader NHS ambitions, as it is part of a government-backed initiative aimed at “turbocharging” clinical research across the NHS. By improving capacity for commercial trials and fostering innovation, OUH is positioned to contribute significantly to advancements in medical research and patient care.